BioNano Genomics (BNGO) Q3 2021 Earnings Report
0 Followers
MX:BNGO Q3 2021 EPS Results
- Actual EPS
- -MXN 786.52
- Consensus EPS
- -MXN 646.91
- Beat/Miss
- Missed by -MXN 139.61
- One Year Ago EPS
- -MXN 898.88
MX:BNGO Q3 2021 Revenue Results
- Actual Revenue
- MXN 87.17M
- Expected Revenue
- MXN 79.06M
- Beat/Miss
- Beat by +MXN 8.11M
- YoY Revenue Growth
- +111.98%
Earnings Announcement Details
- Quarter
- Q3 2021
- Date
- 11/04/2021
- Time
- After Close
- Conference Call
- Thursday, November 4, 2021
MX:BNGO Upcoming Earnings
BioNano Genomics's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q3 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:BNGO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -8.43- | -38.2 | ― | ― |
| Aug 10, 2026 | 2026 (Q2) | -12.55-12.36 | -37.45 | 67.00% (+25.09) | |
| May 13, 2026 | 2026 (Q1) | -16.48-14.23 | -21.54 | 33.91% (+7.30) | |
| Mar 23, 2026 | 2025 (Q4) | -46.35-29.03 | -227.25 | 87.23% (+198.22) | |
| Nov 13, 2025 | 2025 (Q3) | -38.86-38.20 | -584.27 | 93.46% (+546.07) | |
| Aug 14, 2025 | 2025 (Q2) | -49.76-37.45 | -269.66 | 86.11% (+232.21) | |
| May 14, 2025 | 2025 (Q1) | ―- | -674.16 | ― | |
| Mar 31, 2025 | 2024 (Q4) | -56.61-21.54 | -674.16 | 96.81% (+652.62) | |
| Nov 13, 2024 | 2024 (Q3) | -221.93-584.27 | -3617.98 | 83.85% (+3033.71) | |
| Aug 07, 2024 | 2024 (Q2) | -466.63-269.66 | -1393.26 | 80.65% (+1123.60) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
